Abstract:Cardiovascular diseases plague human health because of the lack of transplantable small-diameter blood vessel (SDBV) grafts. Although expanded polytetrafluoroethylene (ePTFE) has the potential to be used as a biocompatible material for SDBV grafts, long-term patency is still the biggest challenge. As discussed in this paper, by virtue of a novel material formulation and a new and benign alcohol/water lubricating agent, biofunctionalized ePTFE blood vessel grafts aimed at providing long-term patency were fabricated. Compared to the most prevalent modification of PTFE, namely surface treatment, this method realized bulk treatment, which could guarantee homogeneous and long-lasting performance throughout PTFE products. These blood vessel grafts included embedded functional biomolecules, such as arginylglycylaspartic acid, heparin, and selenocystamine, using water as a solvent in paste extrusion and in the expansion of ePTFE. Fourier-transform infrared spectroscopy, X-ray photoelectron spectroscopy, and scanning electron microscope results confirmed the existence of these targeting biomolecules in the as-fabricated ePTFE blood vessel grafts. Meanwhile, the greatly improved biological functions of the grafts were demonstrated <i>via</i> live and dead assays, cell morphology, CD31 staining, nitric oxide (NO) release, and anticoagulation tests. This novel and benign material formulation and fabrication method provides an opportunity to produce multibiofunctional ePTFE blood vessel grafts in a single step, thus yielding a potent product with significant commercial and clinical potential.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.biomac.0c00897?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.biomac.0c00897</a>.SEM of ePTFE fabricated by using naphtha as lubricants; SEM of ePTFE with different expanded ratios; XPS survey scans of ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA; fluorescence images of HCAECs cultured on different grafts for 4 h; fluorescence images of HCAECs cultured on ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA grafts for 10 days, respectively; immunochemical staining of HCAECs incubated on neat ePTFE and biofunctionalized ePTFE grafts; and element percentage results of ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA (<a class="ext-link" href="/doi/suppl/10.1021/acs.biomac.0c00897/suppl_file/bm0c00897_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Polyurethane/polyurethane Nanoparticle-Modified Expanded Poly(tetrafluoroethylene) Vascular Patches Promote Endothelialization

A Vascular Patch Fabricated by Cosedimentating Polyurethane and Polymeric Nanoparticles Onto a Decellularized Scaffold Facilitates Endothelialization

A PC-PU Nanoparticle/pu/decellularized Scaffold Composite Vascular Patch: Synergistically Optimized Overall Performance Promotes Endothelialization.

Tetramethylpyrazine-derived Polyurethane for Improved Hemocompatibility and Rapid Endothelialization

Polyurethane-Cardiolipin Nanoparticle-Modified Decellularized Scaffold-Based Vascular Patches for Tissue Engineering Applications

Poly(ferulic Acid)-Hybrid Nanofibers for Reducing Thrombosis and Restraining Intimal Hyperplasia in Vascular Tissue Engineering.

Toward Endothelialization Via Vascular Endothelial Growth Factor Immobilization on Cell-Repelling Functional Polyurethanes.

The in Vivo Performance of Small-Caliber Nanofibrous Polyurethane Vascular Grafts

Preparation of PU/Fibrin Vascular Scaffold with Good Biomechanical Properties and Evaluation of Its Performance in vitro and in vivo

Nanofibers with Homogeneous Heparin Distribution and Protracted Release Profile for Vascular Tissue Engineering

Zwitterionic Polymer-Grafted Polylactic Acid Vascular Patches Based on a Decellularized Scaffold for Tissue Engineering

Decellularized Scaffold-Based Poly(ethylene Glycol) Biomimetic Vascular Patches Modified with Polyelectrolyte Multilayer of Heparin and Chitosan: Preparation and Vascular Tissue Engineering Applications in a Porcine Model.

Biologically Functionalized Expanded Polytetrafluoroethylene Blood Vessel Grafts

A Polyurethane-based Hydrophilic Elastomer with Multi-biological Functions for Small-diameter Vascular Grafts

Small-caliber expanded poly(tetrafluoroethylene) vascular prosthesis impregnated with heparin and polyvinyl alcohol gel

Synthetic Eptfe Grafts Coated with an Anti-Cd133 Antibody-Functionalized Heparin/collagen Multilayer with Rapid in Vivo Endothelialization Properties.

Electrospun compliant heparinized elastic vascular graft for improving the patency after implantation

Expanded polytetrafluoroethylene/silk fibroin/salicin vascular graft fabrication for improved endothelialization and anticoagulation

Multistructured vascular patches constructed via layer-by-layer self-assembly of heparin and chitosan for vascular tissue engineering applications

The Preparation and Performance of a New Polyurethane Vascular Prosthesis